Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Report

Global and Region Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：166
  • REPORT CODE：GMM880677
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)market, defines the market attractiveness level of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) industry, describes the types of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market and the development prospects and opportunities of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market in Chapter 13.

    By Player:

    • Astellas

    • Abbvie

    • Shire

    • Japan Tobacco Company

    • Sanofi Genzyme

    • Akebia

    • Spectrum

    • Daiichi-Sankyo

    • Abbott

    • OPKO

    • Shield

    • Amgen

    • Ardelyx

    • Novadiol

    • Vifor

    • Fresenius

    By Type:

    • Control Hyperphosphatemia

    • Maintain Blood Calcium Levels

    • Control PTH Level

    • Correct Acidosis

    • Other

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    • Drug Stores

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Analysis and Outlook to 2022

    • 7.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)

    • 7.2 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)

    • 7.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)

    • 7.4 China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)

    • 7.5 Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)

    • 7.6 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)

    • 7.7 South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption (2017-2022)

    8 Region and Country-wise Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Analysis and Outlook to 2028

    • 8.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)

    • 8.2 United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)

    • 8.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)

    • 8.4 China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)

    • 8.5 Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)

    • 8.6 India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)

    • 8.7 South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast (2022-2028)

    9 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Outlook by Types and Applications to 2022

    • 9.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Control Hyperphosphatemia Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Maintain Blood Calcium Levels Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Control PTH Level Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Correct Acidosis Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Drug Stores Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Outlook by Types and Applications to 2028

    • 10.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Control Hyperphosphatemia Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Maintain Blood Calcium Levels Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Control PTH Level Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Correct Acidosis Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Competitive Analysis

    • 14.1 Astellas

      • 14.1.1 Astellas Company Details

      • 14.1.2 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • 14.2 Abbvie

      • 14.2.1 Abbvie Company Details

      • 14.2.2 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • 14.3 Shire

      • 14.3.1 Shire Company Details

      • 14.3.2 Shire Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Shire Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • 14.4 Japan Tobacco Company

      • 14.4.1 Japan Tobacco Company Company Details

      • 14.4.2 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • 14.5 Sanofi Genzyme

      • 14.5.1 Sanofi Genzyme Company Details

      • 14.5.2 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • 14.6 Akebia

      • 14.6.1 Akebia Company Details

      • 14.6.2 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • 14.7 Spectrum

      • 14.7.1 Spectrum Company Details

      • 14.7.2 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • 14.8 Daiichi-Sankyo

      • 14.8.1 Daiichi-Sankyo Company Details

      • 14.8.2 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • 14.9 Abbott

      • 14.9.1 Abbott Company Details

      • 14.9.2 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • 14.10 OPKO

      • 14.10.1 OPKO Company Details

      • 14.10.2 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • 14.11 Shield

      • 14.11.1 Shield Company Details

      • 14.11.2 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • 14.12 Amgen

      • 14.12.1 Amgen Company Details

      • 14.12.2 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • 14.13 Ardelyx

      • 14.13.1 Ardelyx Company Details

      • 14.13.2 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • 14.14 Novadiol

      • 14.14.1 Novadiol Company Details

      • 14.14.2 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • 14.15 Vifor

      • 14.15.1 Vifor Company Details

      • 14.15.2 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • 14.16 Fresenius

      • 14.16.1 Fresenius Company Details

      • 14.16.2 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)

    • Figure Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Picture

    • Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption by Country (2017-2022)

    • Figure United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)

    • Table Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)

    • Figure China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)

    • Figure Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)

    • Figure India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast by Country (2022-2028)

    • Figure United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Control Hyperphosphatemia Consumption and Growth Rate (2017-2022)

    • Figure Global Maintain Blood Calcium Levels Consumption and Growth Rate (2017-2022)

    • Figure Global Control PTH Level Consumption and Growth Rate (2017-2022)

    • Figure Global Correct Acidosis Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Stores Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Control Hyperphosphatemia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Maintain Blood Calcium Levels Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Control PTH Level Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Correct Acidosis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Export by Region (Top 5 Countries) (2017-2028)

    • Table Astellas (Foundation Year, Company Profile and etc.)

    • Table Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • Table Abbvie (Foundation Year, Company Profile and etc.)

    • Table Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • Table Shire (Foundation Year, Company Profile and etc.)

    • Table Shire Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • Table Japan Tobacco Company (Foundation Year, Company Profile and etc.)

    • Table Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • Table Sanofi Genzyme (Foundation Year, Company Profile and etc.)

    • Table Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • Table Akebia (Foundation Year, Company Profile and etc.)

    • Table Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • Table Spectrum (Foundation Year, Company Profile and etc.)

    • Table Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • Table Daiichi-Sankyo (Foundation Year, Company Profile and etc.)

    • Table Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • Table Abbott (Foundation Year, Company Profile and etc.)

    • Table Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • Table OPKO (Foundation Year, Company Profile and etc.)

    • Table OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • Table Shield (Foundation Year, Company Profile and etc.)

    • Table Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • Table Ardelyx (Foundation Year, Company Profile and etc.)

    • Table Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • Table Novadiol (Foundation Year, Company Profile and etc.)

    • Table Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • Table Vifor (Foundation Year, Company Profile and etc.)

    • Table Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service

    • Table Fresenius (Foundation Year, Company Profile and etc.)

    • Table Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US